Global Non-Oncology Precision Medicine Market Size By Disease Segmentation, By Therapeutic Segmentation, By Diagnostic Segmentation, By Application ,By Geographic Scope And Forecast
Report ID: 297444|No. of Pages: 202
Global Non-Oncology Precision Medicine Market Size By Disease Segmentation, By Therapeutic Segmentation, By Diagnostic Segmentation, By Application ,By Geographic Scope And Forecast
Non-Oncology Precision Medicine Market Size And Forecast
Non-Oncology Precision Medicine Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period 2024-2031.
Global Non-Oncology Precision Medicine Market Drivers
The market drivers for the Non-Oncology Precision Medicine Market can be influenced by various factors. These may include:
- Developments in Molecular Diagnostics and Genomics: The capacity to sequence genomes and interpret molecular data is becoming more widely available as costs come down and technology advances. This is the main reason why precision medicine techniques are being adopted by many medical specialties outside of oncology.
- Rising Chronic Disease Prevalence: Non-oncology ailments such uncommon genetic disorders, autoimmune diseases, neurological disorders, and cardiovascular diseases are becoming more commonplace worldwide. The market is driven by demand because precision medicine has the potential to provide more individualized, focused, and effective therapies.
- Expanding Personalized Treatment Options: Precision medicine enables medical professionals to customize therapies according to a patient’s genetic composition, lifestyle choices, and environmental circumstances. Precision medicine solutions are embraced by patients and healthcare providers because of the favorable results and decreased side effects that are frequently achieved through this individualized approach.
- Growing Healthcare Spending: Public and commercial sectors are allocating more funds to healthcare infrastructure and research, especially projects aimed at advancing precision medicine. Precision medicine for non-oncology is growing because of this funding, which stimulates innovation in medications, diagnostics, and healthcare delivery paradigms.
- Reimbursement policies and regulatory support: The adoption of precision medicine technology and medicines is greatly influenced by favorable reimbursement and regulatory settings. The market for precision medicine outside of oncology is anticipated to grow as long as regulatory bodies maintain their recognition of the benefits of customized medicine and create structures to facilitate its advancement and incorporation into clinical practice.
- Patient Demand for Personalized Care: Individualized treatment choices are becoming more and more sought after as patients take a more proactive approach to controlling their health. Precision medicine solutions that are not related to cancer are becoming more widely available, which is in line with this trend since patients can benefit from focused therapies that are catered to their individual medical needs and genetic profiles.
- Collaboration and Partnerships: Academic institutions, biotechnology companies, pharmaceutical companies, and healthcare providers are collaborating to drive innovation in precision medicine outside of oncology. By facilitating the creation of novel cures, treatments, and diagnostics, these collaborations contribute to the expansion of the market.
Global Non-Oncology Precision Medicine Market Restraints
Several factors can act as restraints or challenges for the Non-Oncology Precision Medicine Market. These may include:
- Expensive: Personalized medicine, molecular diagnostics, genetic testing, and other advanced technology are frequently used in precision medicine. Cost issues could make therapeutic treatments less accessible, particularly in areas with tight healthcare budgets or trouble with reimbursement.
- Regulatory Challenges: Substantial clinical evidence of safety and efficacy is required for non-oncology precision medicine treatments, and regulatory approval procedures can be drawn out and rigorous. Regulatory approval delays may impede the expansion and uptake of the market.
- Data Security and Privacy Issues: A lot of patient data, including genetic data, medical records, and personal health data, is used in precision medicine. Patients may be discouraged from providing their information or taking part in clinical trials due to worries about data privacy and security, which could hinder the advancement and uptake of precision medicine solutions.
- Interoperability Problems: There are a lot of interoperability problems when integrating different data sources like genomic, clinical trial, and electronic health records (EHRs). The efficacy of precision medicine projects might be curtailed by a lack of standardization and compatibility among various platforms, which can impede data exchange and collaboration among stakeholders.
- Limited Clinical Evidence: Although precision medicine holds great potential, there may not be enough solid clinical data to demonstrate the effectiveness and long-term results of precision medicine treatments used outside of cancer. Adoption rates may be slowed by payers and healthcare professionals who become skeptical due to a lack of proof.
- Ethical and Social Issues: Patients, healthcare providers, and legislators may get alarmed by ethical conundrums involving genetic testing, informed permission, and the use of private health information. It is essential to address these ethical issues in order to foster confidence and guarantee that precision medicine techniques outside of oncology are widely accepted.
- Health Disparities: Based on variables including race, ethnicity, socioeconomic level, and region, disparities in access to healthcare services, particularly precision medicine, can worsen disparities in healthcare outcomes. To guarantee equitable healthcare delivery, initiatives are required to alleviate health disparities and increase underprivileged people’ access to precision medicine.
- Complexity of therapy Algorithms: Personalized therapy techniques based on individual patient features, genetic variants, and other aspects may include sophisticated algorithms and decision-making procedures in non-oncology domains. For these individualized treatment plans to be implemented and optimized, clinician education and training are crucial.
Global Non-Oncology Precision Medicine Market Segmentation Analysis
The Global Non-Oncology Precision Medicine Market is Segmented on the basis of Disease Segmentation, Therapeutic Segmentation, Diagnostic Segmentation, Market Segmentation by Application,and Geography.
Non-Oncology Precision Medicine Market, By Disease
- o Cardiovascular Diseases: Precision medicine solutions targeting conditions such as heart disease, hypertension, and stroke, aiming to personalize treatment based on genetic predispositions and other biomarkers.
- o Neurological Disorders: Precision medicine approaches for diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis, focusing on genetic profiling and targeted therapies to address specific disease pathways.
- o Autoimmune Disorders: Precision medicine solutions for autoimmune conditions like rheumatoid arthritis, lupus, and Crohn’s disease, aiming to identify biomarkers for personalized treatment and management.
Non-Oncology Precision Medicine Market, By Therapeutic
- o Immunotherapy: Precision medicine approaches leveraging the immune system to treat non-oncological diseases, including autoimmune disorders and chronic infections, by modulating immune responses and targeting specific pathways.
- o Pharmacogenomics: Precision medicine strategies focusing on the interplay between genetics and drug response, optimizing medication selection and dosing to improve treatment outcomes and minimize adverse reactions.
- o Regenerative Medicine: Precision medicine techniques utilizing stem cells, gene therapy, and tissue engineering to regenerate damaged tissues and organs, offering potential treatments for conditions like heart failure, spinal cord injuries, and diabetes.
Non-Oncology Precision Medicine Market, By Diagnostic
- o Genetic Testing: Precision diagnostic tests analyzing an individual’s genetic makeup to identify predispositions to certain non-oncological diseases, enabling early intervention and personalized treatment plans.
- o Biomarker Screening: Precision diagnostics detecting specific biomarkers in bodily fluids or tissues associated with non-oncological conditions, facilitating early detection, prognosis, and treatment monitoring.
- o Companion Diagnostics: Precision diagnostic tests designed to identify patients who are likely to benefit from specific non-oncological treatments, guiding treatment decisions and improving therapeutic outcomes.
Non-Oncology Precision Medicine Market, By Application
- o Cardiology: Precision medicine solutions tailored for cardiovascular diseases, including genetic testing for inherited cardiac conditions, targeted therapies for heart failure, and risk stratification for coronary artery disease.
- o Neurology: Precision medicine applications for neurological disorders, such as genetic testing for Alzheimer’s disease risk, biomarker screening for Parkinson’s disease progression, and personalized treatments for epilepsy.
- o Rheumatology: Precision medicine approaches for autoimmune disorders, including pharmacogenomic testing for rheumatoid arthritis medications, biomarker-driven therapies for lupus, and personalized treatment plans for inflammatory bowel disease.
Non-Oncology Precision Medicine Market, By Geographic
- o North America: Analysis of the non-oncology precision medicine market in regions such as the United States and Canada, considering factors like healthcare infrastructure, regulatory landscape, and adoption of precision medicine technologies.
- o Europe: Evaluation of market trends and dynamics in European countries like the UK, Germany, France, and Italy, including factors such as reimbursement policies, research collaborations, and patient access to precision medicine solutions.
- o Asia Pacific: Assessment of market opportunities and challenges in countries like China, Japan, India, and Australia, considering factors such as government initiatives, healthcare expenditure, and advancements in genomic research and technology.
- o Latin America: Examination of the non-oncology precision medicine market in Latin American countries like Brazil, Mexico, and Argentina, including factors such as healthcare infrastructure development, genetic diversity, and adoption of precision medicine in clinical practice.
- o Middle East and Africa: Analysis of market dynamics in regions like the Middle East and Africa, including factors such as disease burden, healthcare investment, and regulatory frameworks shaping the adoption of precision medicine for non-oncological diseases.
Key Players
The major players in the Non-Oncology Precision Medicine Market are:
- Thermo Fisher Scientific Inc.
- QIAGEN
- Illumina, Inc.
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Myriad Genetics Inc.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD | 2020-2031 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2031 |
| HISTORICAL PERIOD | 2020-2022 |
| KEY COMPANIES PROFILED | Lonza Group Ltd., Borax Inc., RUTGERS Organics GmbH, Remmers AG, Sarpap & Cecil Industries. |
| SEGMENTS COVERED | By Disease Segmentation, By Therapeutic Segmentation, By Diagnostic Segmentation, By Market Segmentation by Application, and By Geography. |
| CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF NON-ONCOLOGY PRECISION MEDICINE MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 MARKET ATTRACTIVENESS
4 NON-ONCOLOGY PRECISION MEDICINE MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 NON-ONCOLOGY PRECISION MEDICINE MARKET, BY DISEASE SEGMENTATION
5.1 CARDIOVASCULAR DISEASES
5.2 NEUROLOGICAL DISORDERS
5.3 AUTOIMMUNE DISORDERS
6 NON-ONCOLOGY PRECISION MEDICINE MARKET, BY THERAPEUTIC SEGMENTATION
6.1 IMMUNOTHERAPY
6.2 PHARMACOGENOMICS
6.3 REGENERATIVE MEDICINE
7 NON-ONCOLOGY PRECISION MEDICINE MARKET, BY DIAGNOSTIC SEGMENTATION
7.1 GENETIC TESTING
7.2 BIOMARKER SCREENING
7.3 COMPANION DIAGNOSTICS
8 NON-ONCOLOGY PRECISION MEDICINE MARKET, BY APPLICATION
8.1 CARDIOLOGY
8.2 NEUROLOGY
8.3 RHEUMATOLOGY
9 GLOBAL PRESS RELEASE DISTRIBUTION SOFTWARE MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST AND AFRICA
10 NON-ONCOLOGY PRECISION MEDICINE MARKET GLOBAL COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
10.4 ACE MATRIX
11 COMPANY PROFILES
11.1 PFIZER INC
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.2 NOVARTIS
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.3 ABOTT LABORATIES
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.4 MEDTRONIC
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.5 ALMAC GROUP
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.6 BRISTOL MYERS
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENT
11.9 SQUIBB
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.8 AGILENT TECHNOLOGIES
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENT
11.11 WEILL CORNWELL MEDICINE
11.11.1 OVERVIEW
11.11.2 FINANCIAL PERFORMANCE
11.11.3 PRODUCT OUTLOOK
11.10 OPKO HEALTH INC
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.11 OTHERS
11.11.1 OVERVIEW
11.11.2 FINANCIAL PERFORMANCE
11.11.3 PRODUCT OUTLOOK
12 APPENDIX
12.1 RELATED RESEARCH
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
